Trial Profile
A double-blind, multicenter, randomized, double dummy, three-arm parallel-group comparative study of the efficacy, safety and tolerance of oral NXL 103 versus oral comparator in the treatment of community-acquired pneumonia in adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Linopristin/flopristin (Primary) ; Amoxicillin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Novexel
- 12 Sep 2009 Results reported at ICAAC 2009.
- 11 Sep 2009 Results will be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), according to a Novexel media release.
- 09 Jan 2009 Planned number of patients changed from 300 to 302, according to ClinicalTrials.gov.